Literature DB >> 8631342

Antigenic regions of human chromogranin A and their topographic relationships with structural/functional domains.

A Corti1, R Longhi, A Gasparri, F Chen, M Pelagi, A G Siccardi.   

Abstract

Chromogranin A is a protein contained in the secretory granules of many neuroendocrine cells. The linear antigenic sites of human chromogranin A were studied by examining the cross-reaction of polyclonal and monoclonal anti-chromogranin A antibodies with native chromogranin A and with synthetic peptides encompassing most of the chromogranin A sequence. Chromogranin A residues 1-20, 47-67, 107-158, 254-297, 331-375, and 395-419 were found to be poorly or not antigenic, while residues 25-46, 163-210, 231-253, 298-314 and 68-106, 222-230, 315-330, 376-394 were found to contain weak and strong antigenic sites, respectively. Residues 68-70 (GAK) and 81-90 (GFEDELSEVL) were strongly recognized by two mouse mAbs (B4E11 and A11, respectively). Since mAb A11 has been previously used for immunohistochemical analysis of chromogranin-A-producing tissues from different species and for in vivo imaging of chromogranin-A-positive endocrine tumors, these results imply that at least part of the 81-90 region is surface-exposed in cryostat tissue sections as well as in vivo. The results may help in selecting new antibodies with improved affinity and immunogenicity for in vivo targeting of chromogranin-A-producing tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631342     DOI: 10.1111/j.1432-1033.1996.00275.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration.

Authors:  Cristiano Rumio; Giuseppina F Dusio; Barbara Colombo; Anna Gasparri; Diego Cardani; Fabrizio Marcucci; Angelo Corti
Journal:  Dig Dis Sci       Date:  2012-01-26       Impact factor: 3.199

2.  Role of vasostatin-1 C-terminal region in fibroblast cell adhesion.

Authors:  Eleonora Dondossola; Anna Gasparri; Angela Bachi; Renato Longhi; Marie-Hélène Metz-Boutigue; Bruno Tota; Karen B Helle; Flavio Curnis; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

3.  Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice.

Authors:  Flavio Curnis; Anna Maria Gasparri; Renato Longhi; Barbara Colombo; Silvia D'Alessio; Fabio Pastorino; Mirco Ponzoni; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2012-03-14       Impact factor: 9.261

4.  A new chromogranin A-dependent angiogenic switch activated by thrombin.

Authors:  Luca Crippa; Mimma Bianco; Barbara Colombo; Anna M Gasparri; Elisabetta Ferrero; Y Peng Loh; Flavio Curnis; Angelo Corti
Journal:  Blood       Date:  2012-11-27       Impact factor: 22.113

5.  A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245).

Authors:  F Degorce; Y Goumon; L Jacquemart; C Vidaud; L Bellanger; D Pons-Anicet; P Seguin; M H Metz-Boutigue; D Aunis
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

6.  Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.

Authors:  Andrea Corsello; Luigi Di Filippo; Sara Massironi; Federica Sileo; Anna Dolcetta Capuzzo; Marco Gemma; Claudia Carlucci; Claudio Cusini; Barbara Colombo; Alice Dallatomasina; Giulia Maria Franchi; Angelo Corti; Marco Federico Manzoni
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

7.  Mysterious inhibitory cell regulator investigated and found likely to be secretogranin II related.

Authors:  John E Hart; Iain J Clarke; Gail P Risbridger; Ben Ferneyhough; Mónica Vega-Hernández
Journal:  PeerJ       Date:  2017-10-13       Impact factor: 2.984

8.  Characterisation of circulating chromogranin A in human cancer patients.

Authors:  A Corti; A Gasparri; F X Chen; M Pelagi; A Brandazza; A Sidoli; A G Siccardi
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

9.  Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.

Authors:  Mimma Bianco; Anna Gasparri; Luca Generoso; Emma Assi; Barbara Colombo; Lydia Scarfò; Maria T S Bertilaccio; Cristina Scielzo; Pamela Ranghetti; Eleonora Dondossola; Maurilio Ponzoni; Federico Caligaris-Cappio; Paolo Ghia; Angelo Corti
Journal:  Oncotarget       Date:  2016-07-05

10.  Regulation of tumor growth by circulating full-length chromogranin A.

Authors:  Flavio Curnis; Alice Dallatomasina; Mimma Bianco; Anna Gasparri; Angelina Sacchi; Barbara Colombo; Martina Fiocchi; Laura Perani; Massimo Venturini; Carlo Tacchetti; Suvajit Sen; Ricardo Borges; Eleonora Dondossola; Antonio Esposito; Sushil K Mahata; Angelo Corti
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.